Escherichia coli in the Americas
Bacterial diarrheal diseases remain an important leading cause of preventable death, especially among children under five in developing countries. In the American continent, diarrheal disease and other health complications caused by Escherichia
- PDF / 8,540,615 Bytes
- 393 Pages / 439.42 x 683.15 pts Page_size
- 49 Downloads / 248 Views
Escherichia coli in the Americas
Escherichia coli in the Americas
Alfredo G. Torres Editor
Escherichia coli in the Americas
Editor Alfredo G. Torres Department of Microbiology and Immunology University of Texas Medical Branch Galveston, TX, USA
ISBN 978-3-319-45091-9 ISBN 978-3-319-45092-6 DOI 10.1007/978-3-319-45092-6
(eBook)
Library of Congress Control Number: 2016952245 © Springer International Publishing Switzerland 2016 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer International Publishing AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Foreword
In 1885, a German pediatrician, Theodor Escherich, first described the bacterium Bacterium coli commune as a normal intestinal inhabitant of healthy children. Although his research on this organism, subsequently named Escherichia coli in his honor, is largely remembered for the description of this species as a nonpathogenic, commensal intestinal inhabitant, he also reported in 1894 that B. coli was present in the urine of young girls suffering from urinary tract infections and suggested that it reached the bladder by the ascending route. This was the first description of B. (E.) coli as a potential cause of disease and was followed by Escherich’s 1899 report that B. coli was the cause of dysentery. The latter report was preceded by Kiyoshi Shiga’s 1898 report that the cause of dysentery was a bacterium that he called Bacillus dysenteriae, which was subsequently named Shigella dysenteriae in his honor. Conradi described a neurotoxin from lysates of this organism in 1903 which was later called Shiga toxin. For several decades thereafter, no major advances were made in the study of pathogenic E. coli until the 1944 proposal by Kauffman of a scheme for serological classification of E. coli based on the O (somatic) antigen (a component of the lipopolysaccharide), the H (flage
Data Loading...
